CAR-T Targeting Igβ Targets
/ The First Affiliated Hospital of Soochow University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 04, 2026
Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma
(clinicaltrials.gov)
- P2 | N=0 | Withdrawn | Sponsor: The First Affiliated Hospital of Soochow University | N=12 ➔ 0 | Trial completion date: Feb 2025 ➔ May 2026 | Recruiting ➔ Withdrawn | Trial primary completion date: Feb 2025 ➔ May 2026
Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • B Cell Non-Hodgkin Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
April 05, 2022
Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma
(clinicaltrials.gov)
- P2 | N=12 | Recruiting | Sponsor: The First Affiliated Hospital of Soochow University
CAR T-Cell Therapy • New P2 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 2
Of
2
Go to page
1